Medtronic Is Diving Into the Robotic-Assisted Surgery Market. Can It Compete With the Industry Leader?

Did you know that over $1.6 trillion of America's $4.9 trillion healthcare expenditure in 2023 went to hospitals? You can add up all the spending on physician and clinical services and prescription drugs, and it's still less than we spend on hospitals.Over the past 25 years, hospitals have been learning they can retain more profit from the surgical procedures they perform if they first invest in one of Intuitive Surgical's (NASDAQ: ISRG) da Vinci systems. Hospitals have been beating a path to Intuitive's door to get their hands on its machines, but it isn't the only company developing and marketing surgical robots.In 2014, Medtronic (NYSE: MDT), a giant in the medical-device arena, acquired Mazor Robotics, a company focused on spinal surgeries. More recently, it's been developing its Hugo robot-assisted surgical (RAS) system to tackle procedures typically performed with da Vinci systems.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool